1. Home
  2. MSSA vs OKUR Comparison

MSSA vs OKUR Comparison

Compare MSSA & OKUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MSSA
  • OKUR
  • Stock Information
  • Founded
  • MSSA 2021
  • OKUR 2011
  • Country
  • MSSA United States
  • OKUR United States
  • Employees
  • MSSA N/A
  • OKUR N/A
  • Industry
  • MSSA
  • OKUR
  • Sector
  • MSSA
  • OKUR
  • Exchange
  • MSSA NYSE
  • OKUR NYSE
  • Market Cap
  • MSSA 77.8M
  • OKUR 77.2M
  • IPO Year
  • MSSA 2022
  • OKUR N/A
  • Fundamental
  • Price
  • MSSA $11.80
  • OKUR $5.79
  • Analyst Decision
  • MSSA
  • OKUR Strong Buy
  • Analyst Count
  • MSSA 0
  • OKUR 3
  • Target Price
  • MSSA N/A
  • OKUR $36.00
  • AVG Volume (30 Days)
  • MSSA 2.4K
  • OKUR 176.8K
  • Earning Date
  • MSSA 01-01-0001
  • OKUR 02-14-2025
  • Dividend Yield
  • MSSA N/A
  • OKUR N/A
  • EPS Growth
  • MSSA N/A
  • OKUR N/A
  • EPS
  • MSSA 0.19
  • OKUR N/A
  • Revenue
  • MSSA N/A
  • OKUR N/A
  • Revenue This Year
  • MSSA N/A
  • OKUR N/A
  • Revenue Next Year
  • MSSA N/A
  • OKUR N/A
  • P/E Ratio
  • MSSA $62.20
  • OKUR N/A
  • Revenue Growth
  • MSSA N/A
  • OKUR N/A
  • 52 Week Low
  • MSSA $10.94
  • OKUR $5.75
  • 52 Week High
  • MSSA $14.48
  • OKUR $20.00
  • Technical
  • Relative Strength Index (RSI)
  • MSSA 44.77
  • OKUR N/A
  • Support Level
  • MSSA $11.50
  • OKUR N/A
  • Resistance Level
  • MSSA $11.85
  • OKUR N/A
  • Average True Range (ATR)
  • MSSA 0.48
  • OKUR 0.00
  • MACD
  • MSSA -0.07
  • OKUR 0.00
  • Stochastic Oscillator
  • MSSA 15.96
  • OKUR 0.00

About MSSA METAL SKY STAR ACQUISITION CORP

Metal Sky Star Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.

About OKUR ONKURE THERAPEUTICS INC

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.

Share on Social Networks: